Emerging Pharma Investing Just Got a Whole Lot Smarter

 

Identifying the right companies and understanding the competitive landscape is critical to Pharma fund IRR. And with 30,000 research pubs and 500 clinical trials published weekly, staying current is exceptionally challenging. Amplion delivers continuously updated visibility into the world’s entire biomedical landscape matched precisely to your investment criteria so you can discover, prioritize and monitor your ecosystem.

 

Market-leading investors are leveraging an evidence-based approach to drive ROI. Are you missing out?

Amplion Synthesizes the World’s Biomedical Evidence to Discover, Track and Profile the Investment Opportunities that Matter Most to You

 

33M+

Biomedical
Evidence Sources

analyzed for contextual relevance

 

15k+

Life Science Organizations

continuously monitored

 

85k+

Tracked
Clinical Trials

with disease, pipeline and contact info

 

31k+

New Press Releases, Pubs and Trials

analyzed weekly

Discover, track and qualify opportunities aligned to your growth objectives, automatically.

Identify Tomorrow’s Blockbuster Drug Program Today

Discover relevant emerging drug programs that match your investment criteria and monitor them as they progress through pre-defined research and development phases from pre-IND through trial enrollments and approval. By combining financial, news, conference abstracts, drug development and biomarker data into a unified profile, you can get alerted to that next blockbuster before that big press release hits the wire.

Visualize Technical Due Diligence and Competitive Insights with Remarkable Clarity

The path to drug approval is fraught with scientific challenges and competitors progressing through clinical trials. Amplion’s contextual machine learning coalesces the competitive landscape across multiple dimensions – including biomarker, disease, test and development activity – so you can make informed choices and improve ROI.

Achieve Real-Time Visibility From Early Research to Clinical Approval

By leveraging Amplion’s targeted machine learning and detailed investment criteria, you can track all th R&D activity that matches your investment profile, including early stage research, press announcements, clinical trial progression, partnerships, M&A and funding..

How Amplion Works:
4 Steps to Improving IRR

Define Your Investment Criteria

Specify your drug program investment thesis, including development stages, therapeutic areas, test and biomarker requirements, drug development activities, and financial health.

Discover Emerging Drug Programs

Identify relevant drug programs that match your criteria and enable real-time monitoring, so you can receive push notifications of the compelling events that signal a new opportunity.

Leverage Unbiased Analysis

Improve decision-making and due diligence with a broad, data-driven approach to define the program risks, market opportunity and competitive landscape analysis.

Mute Market Intelligence Noise

Tame the relentless flood of preclinical and clinical evidence with robust filtering to pinpoint relevant program advances and gain immediate access to actionable investment insights.

The only intelligence platform designed for your investment thesis